Design, Synthesis and SAR Studies of Novel and Potent Dipeptidyl Peptidase 4 Inhibitors
设计，合成和小说和有势力 Dipeptidyl Peptidase 4 禁止者的 SAR 研究作者机构：Shanghai Key Laboratory of New Drug DesignSchool of PharmacyEast China University of Science and Technology130 Meilong RoadShanghai 200237China State Key Laboratory of Drug ResearchShanghai Institute of Materia MedicaChinese Academy of Sciences555 Zhuchongzhi RoadShanghai 201203China Shandong Biopolar Dichang Pharmaceutical Co.LtdRM2306No.786 Linzi AvenueZiboShandong 255400China
出 版 物：《Chinese Journal of Chemistry》 (中国化学（英文版）)
年 卷 期：2021年第39卷第1期
页 面：115-120页
核心收录：
学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学]
基 金：This work was supported by the National Key Research and Development Program(No.2016YFA0502304 to H.L.) the National Natural Science Foundation of China(No.81825020 to H.L,No.81803437 to SL.) the National Science&Technology Major Project"Key New Drug Creation and Manufacturing Program",China(No.2018ZX09711002) the Fundamental Research Funds for the Central Universities,Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund(the second phase)under Grant No.U1501501 Shiliang Li is sponsored by Shanghai Sailing Program(No.18YF1405100) Honglin Li is also sponsored by the National Program for Special Supports of Emi nent Professionals and the National Program for Support of Top-notch Young Professionals
主 题：TypeⅡdiabetes Dipeptidyl peptidaseⅣ Inhibitors Molecular docking Structure-activity relationship
摘 要：Dipeptidyl peptidase 4(DPP-4)is a clinically validated target for the treatment of type 2 diabetes mellitus(T2DM).To discover novel and potent DPP-4 inhibitors,three series of compounds were designed and synthesized in this study based on our previously identified novel scaffold of 2-phenyl-3,4-dihydro-2H-benzo[f]*** the designed compounds,41d-1 was the most po tent one with an IC_(50) value of 16.00 nM.
维普期刊数据库